{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T23:08:41Z","timestamp":1789340921589,"version":"build-2803163510"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Science and Technology Major Project of the ministry of Science and Technology of China","award":["2015ZX09102025"],"award-info":[{"award-number":["2015ZX09102025"]}]},{"name":"National Science and Technology Major Project of the ministry of Science and Technology of China","award":["2014ZX09102044-007"],"award-info":[{"award-number":["2014ZX09102044-007"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2015M580592"],"award-info":[{"award-number":["2015M580592"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"State Key Lab of Respiratory Disease, Guangzhou institute of Respiratory Disease","award":["2014SKLRD-O01"],"award-info":[{"award-number":["2014SKLRD-O01"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.antiviral.2016.12.019","type":"journal-article","created":{"date-parts":[[2016,12,28]],"date-time":"2016-12-28T18:01:27Z","timestamp":1482948087000},"page":"55-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"special_numbering":"C","title":["Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice"],"prefix":"10.1016","volume":"140","author":[{"given":"Chong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuexing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Gai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongli","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songtao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.12.019_bib1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/978-94-007-6552-8_21","article-title":"Design of novel vaccines based on virus-like particles or chimeric virions","volume":"68","author":"Barcena","year":"2013","journal-title":"Subcell. Biochem."},{"issue":"1","key":"10.1016\/j.antiviral.2016.12.019_bib2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/meth.1999.0843","article-title":"Parvovirus-like particles as vaccine vectors","volume":"19","author":"Casal","year":"1999","journal-title":"Methods"},{"key":"10.1016\/j.antiviral.2016.12.019_bib3","series-title":"Phase I, Open Label Dose Ranging Safety Study of GLS-5300 in Healthy Volunteers","author":"Clinical Trials.gov","year":"2016"},{"issue":"26","key":"10.1016\/j.antiviral.2016.12.019_bib4","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.vaccine.2014.04.016","article-title":"Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice","volume":"32","author":"Coleman","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.antiviral.2016.12.019_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12967-015-0705-8","article-title":"Cotton rat immune responses to virus-like particles containing the pre-fusion form of respiratory syncytial virus fusion protein","volume":"13","author":"Cullen","year":"2015","journal-title":"J.\u00a0Transl. Med."},{"issue":"17","key":"10.1016\/j.antiviral.2016.12.019_bib6","doi-asserted-by":"crossref","first-page":"9939","DOI":"10.1128\/JVI.01048-13","article-title":"Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development","volume":"87","author":"Du","year":"2013","journal-title":"J.\u00a0Virol."},{"issue":"12","key":"10.1016\/j.antiviral.2016.12.019_bib7","doi-asserted-by":"crossref","first-page":"e81587","DOI":"10.1371\/journal.pone.0081587","article-title":"A\u00a0truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines","volume":"8","author":"Du","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.antiviral.2016.12.019_bib8","doi-asserted-by":"crossref","first-page":"e79575","DOI":"10.1371\/journal.pone.0079575","article-title":"Canine parvovirus VP2 protein expressed in silkworm pupae self-assembles into virus-like particles with high immunogenicity","volume":"9","author":"Feng","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.antiviral.2016.12.019_bib9","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbrc.2003.11.176","article-title":"Assembly of fluorescent chimeric virus-like particles of canine parvovirus in insect cells","volume":"313","author":"Gilbert","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.antiviral.2016.12.019_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1477-3155-4-13","article-title":"Truncated forms of viral VP2 proteins fused to EGFP assemble into fluorescent parvovirus-like particles","volume":"4","author":"Gilbert","year":"2006","journal-title":"J.\u00a0Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.antiviral.2016.12.019_bib11","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ymeth.2006.07.018","article-title":"Virus-like particles: passport to immune recognition","volume":"40","author":"Grgacic","year":"2006","journal-title":"Methods"},{"issue":"5","key":"10.1016\/j.antiviral.2016.12.019_bib12","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1128\/JVI.79.5.2910-2919.2005","article-title":"Synthetic double-stranded RNA poly(I: C) combined with mucosal vaccine protects against influenza virus infection","volume":"79","author":"Ichinohe","year":"2005","journal-title":"J.\u00a0Virol."},{"issue":"45","key":"10.1016\/j.antiviral.2016.12.019_bib13","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1016\/j.vaccine.2014.08.058","article-title":"Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB\/c mice","volume":"32","author":"Kim","year":"2014","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.antiviral.2016.12.019_bib14","doi-asserted-by":"crossref","first-page":"e112602","DOI":"10.1371\/journal.pone.0112602","article-title":"Tailoring subunit vaccine immunity with adjuvant combinations and delivery routes using the Middle East respiratory coronavirus (MERS-CoV) receptor-binding domain as an antigen","volume":"9","author":"Lan","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.antiviral.2016.12.019_bib15","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.ebiom.2015.08.031","article-title":"Recombinant receptor binding domain protein induces partial protective immunity in rhesus macaques against Middle East respiratory syndrome coronavirus challenge","volume":"2","author":"Lan","year":"2015","journal-title":"EBioMedicine"},{"issue":"11","key":"10.1016\/j.antiviral.2016.12.019_bib16","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/cr.2015.113","article-title":"A\u00a0humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein","volume":"25","author":"Li","year":"2015","journal-title":"Cell Res."},{"issue":"4","key":"10.1016\/j.antiviral.2016.12.019_bib17","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/(SICI)1521-4141(199804)28:04<1401::AID-IMMU1401>3.0.CO;2-M","article-title":"A\u00a0recombinant virus-like particle system derived from parvovirus as an efficient antigen carrier to elicit a polarized Th1 immune response without adjuvant","volume":"28","author":"Lo-Man","year":"1998","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.antiviral.2016.12.019_bib18","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1128\/JVI.66.5.2748-2753.1992","article-title":"Recombinant vaccine for canine parvovirus in dogs","volume":"66","author":"Lopez de Turiso","year":"1992","journal-title":"J.\u00a0Virol."},{"issue":"10","key":"10.1016\/j.antiviral.2016.12.019_bib19","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/0264-410X(92)90090-7","article-title":"Production of porcine parvovirus empty capsids with high immunogenic activity","volume":"10","author":"Martinez","year":"1992","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.antiviral.2016.12.019_bib20","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/jphp.12352","article-title":"Particulate inorganic adjuvants: recent developments and future outlook","volume":"67","author":"Maughan","year":"2015","journal-title":"J.\u00a0Pharm. Pharmacol."},{"issue":"18","key":"10.1016\/j.antiviral.2016.12.019_bib21","doi-asserted-by":"crossref","first-page":"8507","DOI":"10.1073\/pnas.91.18.8507","article-title":"Parvovirus particles as platforms for protein presentation","volume":"91","author":"Miyamura","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2016.12.019_bib22","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.vaccine.2016.03.104","article-title":"MERS-CoV vaccine candidates in development: the current landscape","volume":"34","author":"Modjarrad","year":"2016","journal-title":"Vaccine"},{"issue":"16","key":"10.1016\/j.antiviral.2016.12.019_bib23","doi-asserted-by":"crossref","first-page":"9379","DOI":"10.1128\/JVI.01277-13","article-title":"The receptor binding domain of the new Middle East respiratory syndrome coronavirus maps to a 231-residue region in the spike protein that efficiently elicits neutralizing antibodies","volume":"87","author":"Mou","year":"2013","journal-title":"J.\u00a0Virol."},{"issue":"301","key":"10.1016\/j.antiviral.2016.12.019_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac7462","article-title":"A\u00a0synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates","volume":"7","author":"Muthumani","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.antiviral.2016.12.019_bib25","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1200\/JCO.2010.30.7744","volume":"29","author":"Okada","year":"2011","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"36","key":"10.1016\/j.antiviral.2016.12.019_bib26","article-title":"Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013","volume":"18","author":"Perera","year":"2013","journal-title":"Euro Surveill. Bull. Eur. les Mal. Transm.\u00a0= Eur. Commun. disease Bull."},{"key":"10.1016\/j.antiviral.2016.12.019_bib27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jconrel.2015.02.006","article-title":"Polymeric nanoparticles for co-delivery of synthetic long peptide antigen and poly IC as therapeutic cancer vaccine formulation","volume":"203","author":"Rahimian","year":"2015","journal-title":"J.\u00a0Control Release"},{"issue":"1","key":"10.1016\/j.antiviral.2016.12.019_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/viro.1999.9911","article-title":"Minor displacements in the insertion site provoke major differences in the induction of antibody responses by chimeric parvovirus-like particles","volume":"263","author":"Rueda","year":"1999","journal-title":"Virology"},{"issue":"17","key":"10.1016\/j.antiviral.2016.12.019_bib29","doi-asserted-by":"crossref","first-page":"10165","DOI":"10.1128\/JVI.01250-14","article-title":"Modification of the respiratory syncytial virus f protein in virus-like particles impacts generation of B cell memory","volume":"88","author":"Schmidt","year":"2014","journal-title":"J.\u00a0Virol."},{"issue":"25","key":"10.1016\/j.antiviral.2016.12.019_bib30","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1016\/j.vaccine.2014.03.078","article-title":"How advances in immunology provide insight into improving vaccine efficacy","volume":"32","author":"Slifka","year":"2014","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.antiviral.2016.12.019_bib31","doi-asserted-by":"crossref","first-page":"11950","DOI":"10.1128\/JVI.01672-13","article-title":"Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies","volume":"87","author":"Song","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.12.019_bib32","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.antiviral.2015.07.005","article-title":"Animal models of Middle East respiratory syndrome coronavirus infection","volume":"122","author":"van Doremalen","year":"2015","journal-title":"Antivir. Res."},{"issue":"16","key":"10.1016\/j.antiviral.2016.12.019_bib33","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.1128\/JVI.00614-15","article-title":"Protective efficacy of recombinant modified vaccinia virus Ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein","volume":"89","author":"Volz","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.12.019_bib34","doi-asserted-by":"crossref","first-page":"7712","DOI":"10.1038\/ncomms8712","article-title":"Evaluation of candidate vaccine approaches for MERS-CoV","volume":"6","author":"Wang","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2016.12.019_bib35","article-title":"MERS-CoV virus-like particles produced in insect cells induce specific humoural and cellular imminity in rhesus macaques","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.antiviral.2016.12.019_bib36","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1007\/s00253-013-5485-6","article-title":"Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine","volume":"98","author":"Xu","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"1","key":"10.1016\/j.antiviral.2016.12.019_bib37","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1128\/JVI.01848-13","article-title":"Chimeric virus-like particle vaccines displaying conserved enterovirus 71 epitopes elicit protective neutralizing antibodies in mice through divergent mechanisms","volume":"88","author":"Ye","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.12.019_bib38","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/1743-422X-10-266","article-title":"A\u00a0safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV","volume":"10","author":"Zhao","year":"2013","journal-title":"Virology J."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421630393X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421630393X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T09:35:12Z","timestamp":1601285712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635421630393X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":38,"alternative-id":["S016635421630393X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.12.019","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}